Literature DB >> 21165564

Sox4 stimulates ß-catenin activity through induction of CK2.

Ae-Kyung Lee1, Sang-Gun Ahn, Jung-Hoon Yoon, Soo-A Kim.   

Abstract

ß-catenin is a key component of the Wnt signaling pathway and the abnormal accumulation of ß-catenin is characteristic of various types of cancer. Here we demonstrate that overexpression of Sox4 enhances ß-catenin/TCF activity by increasing the stability of ß-catenin. Sox4 increased the protein level of ß-catenin and its target gene cyclin D1 in a dose-dependent manner. An siRNA experiment for Sox4 also demonstrated that Sox4 increases the protein levels of ß-catenin and thus activates the Wnt signaling pathway. We found that induction of ß-catenin/TCF activity by Sox4 is caused by stabilization of the ß-catenin protein, but not by induction of ß-catenin transcription. We further demonstrate that the increased level of ß-catenin is caused by induction of CK2. In light of recent evidence that Sox4 expression is activated in the colon and in other tumors with ß-catenin dysregulation, our findings suggest that Sox4 acts as an agonist of Wnt signaling in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165564     DOI: 10.3892/or.2010.1091

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Sox4 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cell via activation of long noncoding RNA DANCR.

Authors:  Lei Zhang; Shuo Chen; Nirong Bao; Chao Yang; Yunfan Ti; Liwu Zhou; Jianning Zhao
Journal:  J Mol Histol       Date:  2015-10-29       Impact factor: 2.611

2.  Increased expression of SOX4 is associated with colorectal cancer progression.

Authors:  Baochun Wang; Yixiong Li; Fengbo Tan; Zhanxiang Xiao
Journal:  Tumour Biol       Date:  2016-01-14

3.  SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis.

Authors:  Lifang Mu; Lucia Berti; Giacomo Masserdotti; Marcela Covic; Theologos M Michaelidis; Kathrin Doberauer; Katharina Merz; Frederick Rehfeld; Anja Haslinger; Michael Wegner; Elisabeth Sock; Veronique Lefebvre; Sebastien Couillard-Despres; Ludwig Aigner; Benedikt Berninger; D Chichung Lie
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 4.  SOX4: The unappreciated oncogene.

Authors:  Carlos S Moreno
Journal:  Semin Cancer Biol       Date:  2019-08-21       Impact factor: 15.707

5.  MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4.

Authors:  Shujun Li; Xuebo Qin; Yang Li; Xun Zhang; Ren Niu; Helin Zhang; Airong Cui; Wenting An; Xiaolu Wang
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

Review 6.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

7.  Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors.

Authors:  Nevena B Ognjenovic; Meisam Bagheri; Gadisti Aisha Mohamed; Ke Xu; Youdinghuan Chen; Mohamed Ashick Mohamed Saleem; Meredith S Brown; Shivashankar H Nagaraj; Kristen E Muller; Scott A Gerber; Brock C Christensen; Diwakar R Pattabiraman
Journal:  Dev Cell       Date:  2020-10-28       Impact factor: 12.270

8.  Epigenetic regulation of Sox4 during palate development.

Authors:  Ratnam S Seelan; Partha Mukhopadhyay; Dennis R Warner; Cynthia L Webb; Michele Pisano; Robert M Greene
Journal:  Epigenomics       Date:  2013-04       Impact factor: 4.778

9.  miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.

Authors:  Yang Li; Lingling Zu; Yuli Wang; Min Wang; Peirui Chen; Qinghua Zhou
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 10.  Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.

Authors:  Seyed Mehdi Jafarnejad; Gholamreza Safaee Ardekani; Mazyar Ghaffari; Gang Li
Journal:  Cell Mol Life Sci       Date:  2012-10-19       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.